294 related articles for article (PubMed ID: 22150655)
21. Overview and treatment of opioid-induced constipation.
McCarberg BH
Postgrad Med; 2013 Jul; 125(4):7-17. PubMed ID: 23782897
[No Abstract] [Full Text] [Related]
22. Relistor approved for opioid-related constipation.
Traynor K
Am J Health Syst Pharm; 2008 Jun; 65(11):996. PubMed ID: 18499867
[No Abstract] [Full Text] [Related]
23. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
24. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
25. Methylnaltrexone for opioid-induced constipation in advanced illness.
Chappell D; Rehm M; Conzen P
N Engl J Med; 2008 Sep; 359(10):1071; author reply 1071. PubMed ID: 18777614
[No Abstract] [Full Text] [Related]
26. Managing opioid-induced constipation.
Nursing; 2008 Jul; 38(7):55. PubMed ID: 18580669
[No Abstract] [Full Text] [Related]
27. The Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipation.
Lang L
Gastroenterology; 2008 Jul; 135(1):6. PubMed ID: 18549816
[No Abstract] [Full Text] [Related]
28. Drug approvals: '08 in review. Methylnaltrexone (Relistor).
Laustsen G; Carrillo F; Johnson J; Smith C
Nurse Pract; 2009 Feb; 34(2):31. PubMed ID: 19155882
[No Abstract] [Full Text] [Related]
29. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.
Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572
[No Abstract] [Full Text] [Related]
30. Current concepts in the management of opioid-induced constipation: a perfect review with an imperfect concept.
Ruan X
J Opioid Manag; 2011; 7(3):167, 170; author reply 170-2. PubMed ID: 21823547
[No Abstract] [Full Text] [Related]
31. European perspectives on pain and palliative care.
Eisenberg E
J Pain Palliat Care Pharmacother; 2009; 23(2):182-97. PubMed ID: 19492223
[No Abstract] [Full Text] [Related]
32. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
Gatti A; Sabato AF
Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
[TBL] [Abstract][Full Text] [Related]
33. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
34. Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation.
Clark K; Rowett D; Robinson M; Currow DC
BMJ Support Palliat Care; 2013 Mar; 3(1):98-102. PubMed ID: 24644334
[TBL] [Abstract][Full Text] [Related]
35. Methylnaltrexone for opioid-induced constipation.
Belavic JM
Nurse Pract; 2009 Mar; 34(3):6-7. PubMed ID: 19240629
[No Abstract] [Full Text] [Related]
36. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Brick N
Clin J Oncol Nurs; 2013 Feb; 17(1):91-2. PubMed ID: 23372103
[No Abstract] [Full Text] [Related]
37. Pain management research goes beyond the obvious.
Thompson CA
Am J Health Syst Pharm; 2006 Dec; 63(23):2298, 2302, 2304. PubMed ID: 17105998
[No Abstract] [Full Text] [Related]
38. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
Earnshaw SR; Klok RM; Iyer S; McDade C
Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
[TBL] [Abstract][Full Text] [Related]
39. Methylnaltrexone in palliative care: further research is needed.
Clark K; Currow DC
J Pain Symptom Manage; 2014 Feb; 47(2):e5-6. PubMed ID: 24411184
[No Abstract] [Full Text] [Related]
40. GI relief may come sooner than later for patients with chronic noncancer pain.
Thompson CA
Am J Health Syst Pharm; 2014 Jul; 71(14):1153-5. PubMed ID: 24973366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
